Rising to the Challenges of Clinical Trial Improvement in Parkinson's Disease.

PubWeight™: 0.81^‹?›

🔗 View Article (PMID 25720445)

Published in J Parkinsons Dis on June 01, 2015

Authors

Soania Mathur¹^,2, Steve DeWitte²^,3, Israel Robledo²^,3, Tom Isaacs²^,4, Jon Stamford²^,4

Author Affiliations

1: Designing a Cure Inc, Toronto, Canada.
2: Parkinson's Movement, London, UK.
3: Parkinson's Action Network, Washington, DC, USA.
4: The Cure Parkinson's Trust, London, UK.

Articles citing this ↘

Clinical trials from the patient perspective: survey in an online patient community. BMC Health Serv Res (2017) 0.75

Feasibility of a randomized single-blind crossover trial to assess the effects of the second-generation slow-release dopamine agonists pramipexole and ropinirole on cued recall memory in idiopathic mild or moderate Parkinson's disease without cognitive impairment. Pilot Feasibility Stud (2017) 0.75

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials. Trials (2017) 0.75

Articles by these authors ⇆

Challenges of Improving Patient-Centred Care in Parkinson's disease. J Parkinsons Dis (2016) 0.75